Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Ankle Fracture Healing
NCT03765619Phase 1Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin in venous thromboembolism (VTE) (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Ankle Fracture Healing at 12 months. Started Jun 2019; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03765619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03765619.